DocWire News Editors

DocwireNews

The use of continuous glucose monitors (CGMs) in managing type 1 diabetes (T1D) in pediatric patients may reduce hypoglycemia and improve glycemic control as well as satisfaction with care and technology use, according to new research.
The findings of two studies— Strategies to Enhance New Continuous Glucose Monitoring Use in Early Childhood (SENCE) and GM Intervention in Teens and Young Adults With Type 1 Diabetes (CITY)—were presented at the American Diabetes Association’s (ADA’s) 79th Scientific Sessions at the Moscone Convention Center in San Francisco.
In the SENCE study, researchers randomized 143 children (age range, two to seven years) into three groups: self-monitoring of blood glucose with a glucose meter and test strips, CGM, and CGM along with five 30-minute educational family behavioral intervention (FBI) sessions. At baseline, about 40% of patients’ time was spent in a target range of 70-180 mg/dL and 55% was higher than this range. The groups showed no time or difference in time-to-target range across the whole study period. But when comparing baseline figures to those from the end of the study, the CGM + FBI group demonstrated improved time-in-range. Children using CGM spent less time in glucose ranges less than 70 mg/dL and higher than 300 mg/dL; they also had more stable blood sugar levels and fewer severe low blood sugar events. After 26 weeks, the CGM + FBI group reported higher satisfaction with diabetes technology and said they felt less burdened by their diabetes care and less worried about hypoglycemia compared to the other two groups.
In the CITY study, researchers randomized 153 patients (age range, 14–24 years) with disease duration ≥ 12 months to either a Dexcom CGM device or self-monitoring of blood glucose. The primary outcome was six-month A1c levels. Patients had reduced hemoglobin A1c levels and reduced time blood glucose values were hyperglycemic or hypoglycemic. Most of the CGM patients (about 70%) wore the device, on average, at least five days a week; after six months, less than 10% of patients were no longer using the CGM. Glucose monitoring satisfaction was higher among the CGM group compared to the self-monitoring meter cohort.

Laura Litwin

INTEGRATE IIa: Analyzing Regorafenib for Overall Survival in Refractory Advanced Gastric Cancer

Gastric Cancer

Combination Nadunolimab With Gemcitabine, Nab-Paclitaxel Shows “Promising Efficacy” in Patients With Pancreatic Cancer

Pancreatic Cancer

Rob Dillard

Novel Computational Tool Can Predict Immunotherapy Outcomes for Patients With Triple-Negative Breast Cancer

Breast Cancer

Latest News

Effect of Continuous Glucose Monitors on Glycemic Outcomes in Young Diabetic Patients

American Diabetes Association Scientific Sessions 2019

The use of continuous glucose monitors (CGMs) in managing type 1 diabetes (T1D) in pediatric patients may reduce hypoglycemia and improve glycemic control as well as ...

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

GEP-NETs

GIST

Liver Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Career Center

Expert Interviews

Subscribe